Effects on brain tumor cell proliferation by an adenovirus vector that bears the interleukin-4 gene

Journal of NeuroVirology

Volumn 4, Issue 2, 1998, Pages 237-241

  Wei, Ming X ^a   Li, Fangqin ^a   Ono, Yasuhiro ^a   Gauldie, Jack ^b   Chiocca, E Antonio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Brain tumors; Gene therapy; Interleukin 4; Recombinant adenovirus vectors

Indexed keywords

BETA GALACTOSIDASE; INTERLEUKIN 4;

ADENOVIRUS; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN TUMOR; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GENE THERAPY; GLIOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENE;

EID: 0031981427     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289809114523     Document Type: Article

References (24)

1. Addison CL, Gauldie J, Muller WJ, Graham FL (1995). An adenoviral vector expressing interleukin-4 modulates tumorigenicity and induces regression in a murine breast cancer model, Int J Oncol 7: 1253 - 1260.
2. Akli S, Caillaud C, Vigne E, Stratford-Perricaudet LD, Poenaru L, Perricaudet M, Kahn A, Peschanski M (1993). Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genetics 3: 224-228.
3. Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A (1993). Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genetics 3: 229-234.
4. Benda P, Someda K, Messer J, Sweet WH (1971). Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture. J Neurosurg 34: 310-323.
5. Boviatsis EJ, Chase M, Wei MX, Tamiya T, Hurford Jr RK, Kowall NW, Tepper RI, Breakefield XO, Chiocca EA (1994). Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus (HSV), and retrovirus vectors. Hum Gene Ther 5: 183-191.
6. Chen SH, Shine SD, Goodman JC, Grossman RG, Woo SLC (1994). Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 91: 3054-3057.
7. Chiocca EA, Andersen JK, Takamiya Y, Martuza RL, Breakefield XO (1994). Virus-mediated genetic treatment of rodent gliomas, In: Gene Therapeutics, Wolff JA. (ed), Birkhauser Publishers, Boston, MA, pp 245-262.
8. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550-1552.
9. Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ (1993). A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genetics 3: 219-223.
10. Hoshino T, Nagashima T, Cho KG, Murovic JA, Hodes JE, Wilson CB, Edwards MS, Pitts LH (1986). S-phase fraction of human brain tumors in situ measured by uptake of bromodeoxyuridine. International Journal of Cancer 38: 369-374.
11. La Gal La Salle G, Robert JJ, Berrard S, Ridoux V, Stratford-Perricaudet LD, Perricaudet M, Mallet J (1993). An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259, 988-990.
12. Mahaley Jr MS, Mettlin C, Natarajan N, Laws Jr ER, Peace BB (1989). National survey of patterns of care for brain-tumor patients. J Neurosurg 71: 826-836.
13. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
14. Ram Z, Culver KW, Wallbridge S, Blaese RM, Oldfield EH (1993). In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 53: 83-88.
15. Schoenberg BS (1983). The epidemiology of nervous system tumors. In: Walker MD (ed). Oncology of the Nervous System. Martinus Nijhoff, Boston.
16. Takamiya Y, Short MP, Ezzedine ZD, Moolten FL, Breakefield XO, Martuza RL (1992). Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. Journal of Neuroscience Research 33: 493-503.
17. Takamiya Y, Short MP, Moolten FL, Fleet C, Mineta R, Breakefield XO, Martuza RL (1993). An experimental model of retorvirus gene therapy for malignant brain tumors. J Neurosurg 79: 104-110.
18. Tepper RI, Mule JJ (1994). Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther 5: 153-164.
19. Wei MX, Tamiya T, Chase M, Boviatsis EJ, Chang TKH, Kowall NW, Hochberg FH, Waxman DJ, Breakefield XO, Chiocca EA (1994). Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene. Hum Gene Ther 5: 969-978.
20. Wei MX, Tamiya T, Breakefield XO, Chiocca EA (1995a). Viral vector mediated-transfer of drug-sensitivity genes for experimental brain tumor therapy. In: Viral vectors: tools for study and genetic manipulation of the nervous system. Kaplitt MG, Loewy AD. (ed). Academic Press, Orlando. pp 239-253.
21. Wei MX, Tamiya T, Hurford Jr RK, Boviatsis EJ, Tepper RI, Chiocca EA (1995b), Enhancement of Interleukin 4-mediated tumor regression in athymic mice by in situ retroviral gene transfer. Hum Gene Ther 6: 437-443.
22. Yoshii Y, Maki Y, Tsuboi K, Tomono Y, Nakagawa K, Hoshino T (1986). Estimation of growth fraction with bromodeoxyuridine in human central nervous system tumors. J Neurosurg 65, 659-663.
23. Yu JS, Wei MX, Chiocca EA, Martuza RL, Tepper RI (1993). Treatment of glioma by engineered interleukin 4-secreting cells. Cancer Res 53: 3125-3128.
24. Zeng M, Cerniglia GJ, Eck SL, Stevens CW (1997). High-efficiency gene transfer of adenovirus into mammalian cells using ionizing radiation. Hum Gen Ther 8: 1025-1032.